RhumbLine Advisers’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,612
| Closed | -$247K | – | 3053 |
|
|
2020
Q4 | $247K | Buy |
21,612
+2,074
| +11% | +$23.6K | ﹤0.01% | 2754 |
|
|
2020
Q3 | $135K | Sell |
19,538
-3,649
| -16% | -$24K | ﹤0.01% | 2806 |
|
|
2020
Q2 | $151K | Sell |
23,187
-1,859
| -7% | -$12K | ﹤0.01% | 2860 |
|
|
2020
Q1 | $166K | Buy |
25,046
+770
| +3% | +$6.71K | ﹤0.01% | 2643 |
|
|
2019
Q4 | $252K | Buy |
24,276
+179
| +0.7% | +$1.53K | ﹤0.01% | 2675 |
|
|
2019
Q3 | $152K | Buy |
24,097
+1,332
| +6% | +$9.9K | ﹤0.01% | 2814 |
|
|
2019
Q2 | $169K | Buy |
22,765
+5,512
| +32% | +$36.4K | ﹤0.01% | 2832 |
|
|
2019
Q1 | $106K | Buy |
17,253
+28
| +0.2% | +$324 | ﹤0.01% | 2852 |
|
|
2018
Q4 | $198K | Buy |
17,225
+5,549
| +48% | +$94.7K | ﹤0.01% | 2737 |
|
|
2018
Q3 | $253K | Sell |
11,676
-720
| -6% | -$13.6K | ﹤0.01% | 2608 |
|
|
2018
Q2 | $195K | Buy |
+12,396
| New | +$195K | ﹤0.01% | 2742 |
|
|
2017
Q4 | – | Sell |
-13,443
| Closed | -$201K | – | 2862 |
|
|
2017
Q3 | $201K | Buy |
13,443
+60
| +0.4% | +$943 | ﹤0.01% | 2735 |
|
|
2017
Q2 | $248K | Buy |
13,383
+354
| +3% | +$6.15K | ﹤0.01% | 2653 |
|
|
2017
Q1 | $220K | Buy |
+13,029
| New | +$260K | ﹤0.01% | 2623 |
|
|
2016
Q3 | – | Sell |
-7,775
| Closed | -$225K | – | 2953 |
|
|
2016
Q2 | $225K | Buy |
+7,775
| New | +$216K | ﹤0.01% | 2684 |
|
RhumbLine Advisers's ARA Position: Q1 2021 in Review
RhumbLine Advisers sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 21,612 shares — an estimated $247K sold.
RhumbLine Advisers first reported a position in ARA in Q2 2016 and held it in 15 quarters. The position peaked at $253K in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- RhumbLine Advisers reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- RhumbLine Advisers sold 21,612 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $247K.
- RhumbLine Advisers first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 15 quarters.
- RhumbLine Advisers's American Renal Associates Holdings, Inc position peaked at $253K in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.